Contrast-enhanced sonography in the diagnosis of small hepatocellular carcinoma ≤2 cm

Journal of Clinical Ultrasound

Volumn 36, Issue 5, 2008, Pages 257-266

  Xu, Hui Xiong ^a   Xie, Xiao Yan ^a   Lu, Ming De ^a   Liu, Guang Jian ^a   Xu, Zuo Feng ^a   Zheng, Yan Lin ^a   Liang, Jin Yu ^a   Chen, Li Da ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Contrast enhanced sonography; Diagnosis; Hepatocellular carcinoma; Liver

Indexed keywords

SONOVUE; SULFUR HEXAFLUORIDE;

ADULT; AGED; ARTICLE; CANCER SIZE; COLOR ULTRASOUND FLOWMETRY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; EVALUATION; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE ENHANCEMENT; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MICROBUBBLE; PERFORMANCE; PREDICTION; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; BIOPSY; CARCINOMA, HEPATOCELLULAR; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MICROBUBBLES; MIDDLE AGED; NEOPLASM STAGING; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SULFUR HEXAFLUORIDE; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 44349115147     PISSN: 00912751     EISSN: 10970096     Source Type: Journal    
DOI: 10.1002/jcu.20433     Document Type: Article

References (26)

1. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999;80:827.
2. Xu HX, Xie XY, Lu MD, et al. Ultrasound-guided percutaneous thermal ablation of hepatocellular carcinoma using microwave and radiofrequency ablation. Clin Radiol 2004;59:52.
3. Sherman M. Diagnosis of small hepatocellular carcinoma. Hepatology 2005;42:14.
4. Gaiani S, Celli N, Piscaglia F, et al. Usefulness of contrast-enhanced perfusional sonography in the assessment of hepatocellular carcinoma hypervascular at spiral computed tomography. J Hepatol 2004;41:421.
5. Ikeda K, Saitoh S, Koida I, et al. Diagnosis and follow-up of small hepatocellular carcinoma with selective intraarterial digital subtraction angiography. Hepatology 1993;17:1003.
6. Chen RC, Wang CK, Wang CS, et al. Depiction of vasculature in small hepatocellular carcinoma, and dysplastic nodules: evaluation with carbondioxide ultrasonography and angiography. Acta Radiol 2002;43:66.
7. Kubota K, Hisa N, Fujiwara Y, et al. Evaluation of the intratumoral vasculature of hepatocellular carcinoma by power Doppler sonography: advantages and disadvantages versus conventional color Doppler sonography. Abdom Imaging 2000;25:172.
8. Dill-Macky MJ, Burns PN, Khalili K, et al. Focal hepatic masses: enhancement patterns with SHU 508A and pulse-inversion US. Radiology 2002;222:95.
9. Kim TK, Choi BI, Han JK, et al. Hepatic tumors: contrast agent-enhancement patterns with pulse-inversion harmonic US. Radiology 2000;216:411.
10. Xu HX, Liu GJ, Lu MD, et al. Characterization of small focal liver lesions using real-time contrast-enhanced sonography: diagnostic performance analysis in 200 patients. J Ultrasound Med 2006;25:349.
11. Xu HX, Lu MD, Liu GJ, et al. Imaging of peripheral cholangiocarcinoma using low mechanical index contrast-enhanced sonography and SonoVue: initial experience. J Ultrasound Med 2006;25: 23.
12. Bolondi L, Gaiani S, Celli N, et al. Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology 2005;42:27.
13. Quaia E, Calliada F, Bertolotto M, et al. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. Radiology 2004;232:420.
14. Ding H, Wang WP, Huang BJ, et al. Imaging of focal liver lesions: low-mechanical-index real-time ultrasonography with SonoVue. J Ultrasound Med 2005;24:285.
15. von Herbay A, Vogt C, Willers R, et al. Real-time imaging with the sonographic contrast agent SonoVue: differentiation between benign and malignant hepatic lesions. J Ultrasound Med 2004;23:1557.
16. Macdonald GA, Peduto AJ. Magnetic resonance imaging (MRI) and diseases of the liver and biliary tract. Part 1. Basic principles, MRI in the assessment of diffuse and focal hepatic disease. J Gastroenterol Hepatol 2000;15:980.
17. Nino-Murcia M, Olcott EW, Jeffrey RB Jr, et al. Focal liver lesions: pattern-based classification scheme for enhancement at arterial phase CT. Radiology 2000;215:746.
18. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005;42:1208.
19. Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001;35:421.
20. Bleuzen A, Tranquart F. Incidental liver lesions: diagnostic value of cadence contrast pulse sequencing (CPS) and SonoVue. Eur Radiol 2004;14(Suppl 8):P53.
21. Greis C. Technology overview: SonoVue (Bracco, Milan). Eur Radiol 2004;14(Suppl 8):P11.
22. Albrecht T, Blomley M, Bolondi L, et al. Guidelines for the use of contrast agents in ultrasound. January 2004. Ultraschall Med 2004;25:249.
23. Nicolau C, Brú C. Focal liver lesions: evaluation with contrast-enhanced ultrasonography. Abdom Imaging 2004;29:348.
24. Durand F, Regimbeau JM, Belghiti J, et al. Assessment of the benefits and risks of percutaneous biopsy before surgical resection of hepatocellular carcinoma. J Hepatol 2001;35:254.
25. Huang GT, Sheu JC, Yang PM, et al. Ultrasound-guided cutting biopsy for the diagnosis of hepatocellular carcinoma: a study based on 420 patients. J Hepatol 1996;25:334.
26. Xu HX, Liu GJ, Lu MD, et al. Characterization of focal liver lesions using contrast-enhanced ultrasound with a low mechanical index mode and a sulfur hexafluoride-filled microbubble contrast agent. J Clin Ultrasound 2006;34: 261.